Neil Gunn

Dr. Neil Gunn is an Independent Director at NeoGenomics, Inc., an Independent Director at Rarecells, Inc. and an Independent Director at Alveo Technologies, Inc. He is on the Board of Directors at NeoGenomics, Inc., Rarecells, Inc., Alveo Technologies, Inc. and Rarecells Diagnostics SAS. Dr. Gunn was previously employed as a Chief Executive Officer & Director by IDbyDNA, Inc., a Non-Executive Director by Genetic Signatures Ltd., a President by Roche Sequencing Solutions, Inc., a Vice President-Commercial Operations by CaridianBCT, Inc., a Vice President-Commercial Operations by Novartis Vaccines & Diagnostics SL, and a Head-Global Business by Roche Molecular Systems, Inc. He received his undergraduate degree from Nottingham Trent University, a graduate degree from the University of Portsmouth and a doctorate degree from the University of Portsmouth.